Chupin Alexey Nikolaevich

Biography

JSC Binnopharm is one of the largest Russian biopharmaceutical companies of the full cycle with its own R & D division. Binnopharm develops and manufactures biotechnological genetically engineered medicines, including the hepatitis B vaccine, in full compliance with international GMP quality standards, carries out the production and wholesale of medicines and pharmaceutical substances. 74% of the company's charter capital belongs to AFK Sistema .   JSC "Binnopharm" has the largest in Russia GMP facilities for the production of vaccines in ampoules (up to 80 million ampoules per year), as well as a unique for Russia complexly equipped quality control laboratory.   The company develops original combined preparations, bio-analogs, completely original and biotechnological preparations of various therapeutic groups: pulmonology, neurology, cardiology, oncology, gastroenterology and endocrinology.   JSC Binnopharm developed and produced a vaccine for children and adults against hepatitis B serotype AYW, which is specific for the territory of the Russian Federation. A special technology for obtaining the product, which has no analogues among Russian manufacturers, allows the production of a vaccine without preservatives containing mercury and to ensure a quality that fully meets international standards. Since 2009, the company "Binnopharm" provides the basic needs of the state in a vaccine against hepatitis.   The structure of JSC Binnopharm includes PFC Alium - a modern complex for the production of infusion solutions, and its own distribution company - Binnopharm Distribution, which sells drugs as JSC Binnopharm, and third-party manufacturers.

Research Interest

pharma